Mark van der Linden

7.7k total citations
203 papers, 4.7k citations indexed

About

Mark van der Linden is a scholar working on Epidemiology, Microbiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark van der Linden has authored 203 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Epidemiology, 63 papers in Microbiology and 50 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark van der Linden's work include Pneumonia and Respiratory Infections (124 papers), Bacterial Infections and Vaccines (56 papers) and Streptococcal Infections and Treatments (48 papers). Mark van der Linden is often cited by papers focused on Pneumonia and Respiratory Infections (124 papers), Bacterial Infections and Vaccines (56 papers) and Streptococcal Infections and Treatments (48 papers). Mark van der Linden collaborates with scholars based in Germany, Belgium and United States. Mark van der Linden's co-authors include Matthias Imöhl, Ralf René Reinert, Stephanie Perniciaro, Rüdiger von Kries, Adnan Al‐Lahham, Simon Rückinger, Gerhard Falkenhorst, Regine Hakenbeck, E. Yourassowsky and Murat Cil and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark van der Linden

199 papers receiving 4.5k citations

Peers

Mark van der Linden

EPIDE

MICRO

PHEOH

Lesley McGee United States

Ralf René Reinert Germany

Emilio Pérez‐Trallero Spain

Susan Petit United States

Angela B. Brueggemann United Kingdom

Carmen Ardanuy Spain

Kimiko Ubukata Japan

Barry J. Hartman United States

Keisuke Sunakawa Japan

Gregory J. Tyrrell Canada

Lesley McGee United States

Mark van der Linden

4.7k ×1.5

EPIDE

2.0k ×1.5

MICRO

1.6k ×1.2

PHEOH

1.0k ×1.0

504 ×1.1

Citations per year, relative to Mark van der Linden Mark van der Linden (= 1×) peers Lesley McGee

Countries citing papers authored by Mark van der Linden

Since Specialization

Citations

This map shows the geographic impact of Mark van der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark van der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark van der Linden more than expected).

Fields of papers citing papers by Mark van der Linden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark van der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark van der Linden. The network helps show where Mark van der Linden may publish in the future.

Co-authorship network of co-authors of Mark van der Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark van der Linden. A scholar is included among the top collaborators of Mark van der Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark van der Linden. Mark van der Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veen, Anneke van, M. Damen, Elisabeth G. W. Huijskens, et al.. (2024). Regional variation in the interpretation of contact precautions for multi-drug-resistant Gram-negative bacteria: a cross-sectional survey. Journal of Hospital Infection. 152. 1–12. 3 indexed citations

Ellingson, Mallory K., Daniel M. Weinberger, Mark van der Linden, & Stephanie Perniciaro. (2023). Potential Impact of Higher-Valency Pneumococcal Conjugate Vaccines Among Adults in Different Localities in Germany. The Journal of Infectious Diseases. 229(6). 1669–1673. 5 indexed citations

Perniciaro, Stephanie, Mark van der Linden, & Daniel M. Weinberger. (2022). Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021. Clinical Infectious Diseases. 75(7). 1149–1153. 55 indexed citations

Ramette, Alban, Silvio D. Brugger, Rémy Bruggmann, et al.. (2021). Carbon Source-Dependent Changes of the Structure of Streptococcus pneumoniae Capsular Polysaccharide with Serotype 6F. International Journal of Molecular Sciences. 22(9). 4580–4580. 9 indexed citations

Both, Ulrich von, Ulrich Matt, Federica Andreoni, et al.. (2020). Characterisation of clinical manifestations and treatment strategies for invasive beta-haemolytic streptococcal infections in a Swiss tertiary hospital. Swiss Medical Weekly. 150(4950). w20378–w20378. 3 indexed citations

Imöhl, Matthias, Christina Fitzner, Stephanie Perniciaro, & Mark van der Linden. (2017). Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS ONE. 12(7). e0180757–e0180757. 34 indexed citations

Segerer, Florian, Christoph Schoen, Mark van der Linden, et al.. (2016). Therapy of 645 children with parapneumonic effusion and empyema—A German nationwide surveillance study. Pediatric Pulmonology. 52(4). 540–547. 26 indexed citations

Linden, Mark van der, et al.. (2015). Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination. Epidemiology and Infection. 144(7). 1563–1573. 9 indexed citations

Nagy, K., et al.. (2014). Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary. European Journal of Pediatrics. 174(3). 373–381. 15 indexed citations

10.

Memish, Ziad A., Abdullah M. Assiri, Malak Almasri, et al.. (2014). Impact of the hajj on pneumococcal transmission. Clinical Microbiology and Infection. 21(1). 77.e11–77.e18. 40 indexed citations

11.

Linden, Mark van der, et al.. (2013). Discovery of Streptococcus pneumoniae Serotype 6 Variants with Glycosyltransferases Synthesizing Two Differing Repeating Units. Journal of Biological Chemistry. 288(36). 25976–25985. 62 indexed citations

12.

Schaumburg, Frieder, Abraham Alabi, Benjamin Mordmüller, et al.. (2012). Carriage of encapsulated bacteria in Gabonese children with sickle cell anaemia. Clinical Microbiology and Infection. 19(3). 235–241. 13 indexed citations

13.

Ludwig, Endre, Serhat Ünal, Miron Alexandru Bogdan, et al.. (2012). Opportunity for Healthy Ageing: Lessening the Burden of Adult Pneumococcal Disease in Central and Eastern Europe, and Israel. Central European Journal of Public Health. 20(2). 121–125. 5 indexed citations

14.

Jiang, Yiling, et al.. (2011). PIN74 A Cost-Effectiveness Analysis of Vaccinating the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Germany. Value in Health. 14(7). A279–A279. 1 indexed citations

15.

Strus, Magdalena, Agnieszka Chmielarczyk, Piotr Kochan, et al.. (2010). Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland. Clinical Microbiology and Infection. 16(9). 1442–1447. 7 indexed citations

16.

Strus, Magdalena, Agnieszka Chmielarczyk, Piotr Kochan, et al.. (2009). Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland. Clinical Microbiology and Infection. 16(9). 1442–7. 7 indexed citations

17.

Yourassowsky, E., Mark van der Linden, & F. Crokaert. (1990). Antibacterial effect of meropenem and imipenem on Proteus mirabilis. Journal of Antimicrobial Chemotherapy. 26(2). 185–192. 8 indexed citations

18.

Yourassowsky, E., et al.. (1989). Growth Curve Patterns ofEscherichia coli, Serratia marcescens,andProteus vulgarisSubmitted to Different Tigemonam Concentrations. Journal of Chemotherapy. 1(sup2). 49–53. 2 indexed citations

19.

Yourassowsky, E., et al.. (1988). Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid againstBranhamella catarrhalis. European Journal of Clinical Microbiology & Infectious Diseases. 7(3). 433–434. 1 indexed citations

20.

Yourassowsky, E., et al.. (1987). Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system. European Journal of Clinical Microbiology & Infectious Diseases. 6(6). 634–636. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact